Sarepta Therapeutics Inc.
SRPT | NASDAQ
$18.32
-$0.30 (-1.61%)
At close: Nov 2, 2026, 4:00 PM ET
$18.85
+$0.23 (+1.24%)
Pre-market:
Nov 2, 2026, 8:54 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 401.25M | 730.8M | 442.93M | 399.36M | 611.09M | 744.86M | 658.41M | 467.17M | 362.93M | 413.46M | 396.78M | 331.82M | 261.24M | 253.5M | 258.43M | 230.27M | 233.49M | 210.83M | 201.46M | 189.41M | 164.09M | 146.93M |
Cost of Revenue | 149.39M | 119.36M | 398.71M | 150.78M | 152.56M | 137.56M | 132.3M | 91.69M | 44.55M | 50.56M | 44.18M | 37.03M | 34.12M | 35.02M | 30.8M | 39.95M | 37.8M | 31.44M | 31.74M | 23.44M | 19.52M | 22.35M |
Gross Profit | 251.87M | 611.44M | 44.23M | 248.58M | 458.53M | 607.29M | 526.11M | 375.48M | 318.39M | 362.91M | 352.61M | 294.79M | 227.11M | 218.48M | 227.63M | 190.32M | 195.69M | 179.39M | 169.72M | 165.96M | 144.57M | 124.59M |
Operating Income | 13.29M | 358.43M | -411.58M | -103.39M | 115.58M | -300.39M | 161.68M | 22.2M | -701K | 34.91M | 24.63M | -20.84M | -133.52M | -138.09M | -106.83M | -131.36M | -211.13M | -86.88M | -105.81M | -34.46M | -167.57M | -151.87M |
Interest Income | 6.21M | 7M | 8.38M | 8.38M | 7.14M | 12.43M | 14.7M | 18.33M | 18.84M | 19.9M | 22.63M | 22.82M | 21.2M | 19.32M | 9.13M | 8.22M | 2.41M | 215K | 95K | 148K | 52K | 59K |
Pretax Income | -1.75M | 343.17M | -278.3M | -194.05M | 153.64M | -383.52M | 171.74M | 34.01M | 13.58M | 41.45M | 40.37M | -33.17M | -14.59M | -512.71M | -101.31M | -256.42M | -228.09M | -104.15M | -121.89M | -47.91M | -81.76M | -167.39M |
Net Income | -4.89M | 330.96M | -282.85M | -179.95M | 196.89M | -447.51M | 159.05M | 33.61M | 6.46M | 36.12M | 45.66M | -40.94M | -23.94M | -516.76M | -109.24M | -257.74M | -231.48M | -105.03M | -121.98M | -48.14M | -81.41M | -167.25M |
Selling & General & Admin | 107.6M | 108.95M | 128.3M | 91.89M | 137.9M | 133.63M | 163.87M | 128.2M | 138.8M | 127M | 131.7M | 120.89M | 118.56M | 110.71M | 120.48M | 104.79M | 154.32M | 71.84M | 78.06M | 61.13M | 72.35M | 71.13M |
Research & Development | 91.26M | 153.96M | 325.34M | 218.89M | 204.39M | 773.45M | 199.95M | 224.48M | 179.69M | 200.4M | 195.52M | 194.3M | 241.89M | 245.68M | 213.8M | 216.71M | 252.33M | 194.25M | 197.3M | 139.12M | 239.62M | 195.15M |
Other Expenses | 39.72M | -9.9M | 2.18M | 41.19M | 667K | 601K | 601K | 602K | 601K | 601K | 763K | 439K | 179K | 178K | 179K | 178K | 179K | 178K | 179K | 178K | 179K | 10.17M |
Operating Expenses | 238.58M | 253.01M | 455.81M | 351.97M | 342.96M | 907.68M | 364.43M | 353.29M | 319.09M | 328M | 327.98M | 315.63M | 360.63M | 356.57M | 334.46M | 321.67M | 406.82M | 266.27M | 275.53M | 200.42M | 312.15M | 276.45M |
Interest Expense | 21.51M | 21.71M | 7.57M | 7.57M | 5.23M | 4.5M | 4.48M | 4.92M | 4.83M | 4.17M | 5.23M | 5.23M | 5.22M | 6.32M | 6.69M | 14.74M | 16.03M | 15.8M | 16.05M | 16M | 15.83M | 15.65M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 387.96M | 372.37M | 854.52M | 502.75M | 495.51M | 1.05B | 496.73M | 444.98M | 363.63M | 378.56M | 372.16M | 352.66M | 394.76M | 391.59M | 365.26M | 361.62M | 444.62M | 297.71M | 307.27M | 223.86M | 331.66M | 298.8M |
Income Tax Expense | 3.14M | 12.22M | 4.55M | -14.1M | -43.25M | 63.99M | 12.69M | 395K | 7.12M | 5.33M | -5.28M | 7.76M | 9.36M | 4.05M | 7.94M | 1.32M | 3.39M | 879K | 92K | 237K | -354K | -143K |
Shares Outstanding (Basic) | 105.43M | 104.99M | 104.79M | 100.24M | 98.01M | 97.36M | 96.28M | 95.39M | 94.62M | 93.99M | 93.62M | 88.89M | 88.74M | 88.19M | 87.84M | 87.63M | 87.35M | 87.25M | 84.26M | 79.88M | 79.75M | 79.45M |
Shares Outstanding (Diluted) | 105.43M | 121.92M | 104.79M | 100.24M | 106.62M | 97.36M | 108.47M | 100.45M | 99.14M | 99.11M | 105.59M | 88.89M | 88.74M | 88.19M | 87.84M | 87.63M | 87.51M | 87.25M | 84.26M | 79.88M | 79.75M | 79.45M |
EPS (Basic) | -0.05 | 3.15 | -2.74 | -1.80 | 2.01 | -4.60 | 1.65 | 0.35 | 0.07 | 0.38 | 0.49 | -0.46 | -0.27 | -5.86 | -1.24 | -2.94 | -2.65 | -1.20 | -1.45 | -0.60 | -1.02 | -2.10 |
EPS (Diluted) | -0.05 | 2.88 | -3.93 | -1.80 | 1.89 | -4.60 | 1.50 | 0.33 | 0.07 | 0.37 | 0.43 | -0.46 | -0.27 | -5.86 | -1.24 | -2.94 | -2.65 | -1.20 | -1.45 | -0.60 | -1.02 | -2.10 |
EBITDA | 30.17M | 375.48M | -252.2M | -168.03M | 169.71M | -369.04M | 186.67M | 48.73M | 27.13M | 54.36M | 56.98M | -17.02M | 1.43M | -495.08M | -84.07M | -230.98M | -202.18M | -77.63M | -95.7M | -21.42M | -57.48M | -142.81M |
EBIT | 19.76M | 364.89M | -257.45M | -186.48M | 158.87M | -379.02M | 176.22M | 38.92M | 18.41M | 45.61M | 45.61M | -27.95M | -9.36M | -506.39M | -94.62M | -241.68M | -212.07M | -88.35M | -105.84M | -31.91M | -65.93M | -151.74M |
Depreciation & Amortization | 10.41M | 10.59M | 5.25M | 18.45M | 10.84M | 9.98M | 10.46M | 9.81M | 8.72M | 8.74M | 11.37M | 10.93M | 10.79M | 11.31M | 10.55M | 10.7M | 9.89M | 10.72M | 10.15M | 10.5M | 8.45M | 8.93M |
Add to Watchlist
Select watchlists to add or remove SRPT